Skip to content
‹ Back to IndustriesSciences

How the Indestructible Molecule that is PFAS Effects the Environment

Jason Claybrook and guest Yuran Li discuss the environmental impact of Per and Polyfluoroalkyl Substances (PFAS) on the show 'There's More to IT'. PFAS are manmade chemicals used in many products for their water and oil repellent properties, but they present a significant environmental hazard. These substances do not break down easily, leading to bioaccumulation and potential health risks.

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Jason Claybrook · · EnvironmentEnvironmental Protection AgencyHealthMolecule
Share
How the Indestructible Molecule that is PFAS Effects the Environment

Key takeaways

01

PFAS are widely used chemicals that repel water and oil, making them prevalent in products like cookware and paint.

02

PFAS do not break down in the environment, leading to accumulation in living organisms and posing a health risk.

03

Current studies are examining the toxicity of PFAS and its links to health issues such as cancer and thyroid problems.

Free workspace

Turn your Sciences expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

In the most recent episode of “There’s More to IT,” host Jason Claybrook discussed the widespread exposure of Per and Polyfluoroalkyl Substances, better known as PFAS, in various aspects of everyday life. His guest was Yuran Li, the director of MS Commercial Strategies at Alternative Biomedical Solutions — a Texas based laboratory. The two talked about just what PFAS is, and why the molecules’ existence is harmful.

PFAS is a manmade chemical that repels water and oil, which also makes it a highly preferable component for some commonly-used products. This can include cookware, food wrappings, and paint, according to Li. The first use of PFAS began in the 1940s, and it evidently found its way into various products due to its resistant qualities. And due to that fact, the initial inference of the safety of PFAS was misleading, per Li.

“There is no natural occurrence of this type of molecule, and because everything gets repelled from it, there was always this assumption early on when it was invented, that it’s harmless,” said Li.

But decades later and after many studies, even by the U.S. Environmental Protection Agency (EPA), it has been concluded the concerns regarding PFAS are major harm to the environment and living beings.

PFAS does not break down into the environment the way other molecules can, which means it presents a different type of danger for the environment. And just based on bioaccumulation, PFAS’ has found its way into every living organism, said Li.

Current studies are still in the early stages of determining just how toxic PFAS can be to the human body, and what levels would be considered a cause for immediate concern. But there is a connection between it and other health issues, said Li.

“Some of the early links were cancers, thyroid issues is one of the biggest ones being investigated at the moment, and pregnancy issues,” said Li.

People with major thyroid problems and hormonal imbalances were shown to have a lot of exposure to PFAS, added Li. But he stated that the studies between PFAS and infertility is a growing concern that is taking precedence.

Even more daunting is the formidablilty of PFAS. Being that it cannot break down environmentally, that also means it doesn’t break down in the body either. Subsequently, the response for health issues or symptoms related to PFAS is basic treatment. But even treatment like chemotherapy or cancer medications can’t break down the substance.

Li joked that even diamonds aren’t as long-lasting, and stated that PFAS is expected to be around for a long time due to the weight of effort that even needs to be made just to fully eliminate it. For example, if PFAS ends up in wildlife, it is expected to be there practically forever.

“It will take millions of years before they would even begin to start breaking down — that’s how strong that molecules’ bonds are,” said Li. “Right now the only method really of getting rid of PFAS is really high heat incineration.”

Only extremely high heat can destroy PFAS, but even if that method was widely utilized, it would create another domino effect of environmental issues such as harming the natural water supply.

The Industry That is Depending on Science and Regulation to Grow

Is Cryptocurrency and Its Tech Infrastructure Ready for a Revolution?

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

JC
Jason Claybrook
B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Sciences Insights

Antibody developability checks are moving into discovery instead of waiting for development

Antibody developability checks are moving into discovery instead of waiting for development

Maria Gonzalez-Pajuelo of FairJourney Bio says the order in antibody discovery is changing: developability has become a much more important consideration during discovery, rather than an issue left until later-stage development. The goal, she says, is that what comes out of discovery is something CMC can take forward easily.

  • 01Discovery-stage developability screens can rank many antibodies tested once or twice and may reduce surprises later in development, while development still focuses on several lots of a single antibody and answers different questions.

Oct 1, 2026

Caraballo expects AI across all five tracks at ISPE’s 2026 Annual Meeting

Caraballo expects AI across all five tracks at ISPE’s 2026 Annual Meeting

ISPE’s 2026 Annual Meeting and Expo in Washington, DC organizes its program around five tracks running from discovery to governance, with international program committee chair Connie Langer of Pfizer Global Supply and executive chair Jose Caraballo of JCO Global Advisory LLC describing how the tracks connect—and why AI is treated as a cross-cutting topic rather than a standalone track. Deloitte’s December 2025 survey of 280 executives frames the mood the program is built for.

  • 01ISPE’s 2026 Annual Meeting has no dedicated AI track; executive chair Jose Caraballo expects AI presentations across all five tracks, from discovery to governance.
  • 02Deloitte’s December 2025 survey of 280 biopharma and medtech C-suite executives found more than 75% confident in their own outlook but only 41% optimistic about the global economy, a mood the story says the ISPE chairs are programming for.
  • 03A staffing firm reports life sciences job openings falling even as digital fluency becomes a required skill, so the upskilling burden lands on the people already employed, which is where the mandatory, university-partnered AI training Connie Langer describes at her company sits.

Sep 30, 2026

Crown Bioscience's San Diego site fits the tumor model to the therapy, not the reverse

Crown Bioscience's San Diego site fits the tumor model to the therapy, not the reverse

Crown Bioscience's San Diego site designs preclinical tumor models to match specific therapies and delivery routes, rather than forcing treatments into standard study designs. It combines custom surgical procedures, cell line-derived xenografts, patient-derived xenografts (including post-treatment models), and biomarker capabilities to generate translational data that can help sponsors decide whether to advance a program.

  • 01Orthotopic brain tumor implantation using tagged models lets researchers track tumor growth in the original organ, aligning the model and delivery route with how therapies are intended to be tested.
  • 02Patient-derived xenografts developed from tumors after prior treatment may better reflect progressed disease, helping teams study therapies aimed at patients whose cancer has advanced after earlier treatment.
  • 03Combining biomarker analysis of preclinical model samples with clinical sample testing at one site could make it easier to connect what is measured in animals with what is later measured in patients.

Sep 30, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Experts

JC
Jason Claybrook

Host, There's More to IT

Jason Claybrook is the host of the show 'There's More to IT', where he discusses various topics related to science and technology. He is known for engaging with experts to delve into complex issues affecting everyday life.

YL
Yuran Li

Director of MS Commercial Strategies

Alternative Biomedical Solutions

Yuran Li is the director of MS Commercial Strategies at Alternative Biomedical Solutions, a Texas-based laboratory. He is involved in strategic initiatives and research pertaining to chemical substances like PFAS.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512